Clinical trials data
Digit Span Test in dementia and Alzheimer's trials: 181 registered studies
Every registered dementia and Alzheimer's disease study on ClinicalTrials.gov that names the Digit Span Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered dementia and Alzheimer's disease studies name it in an outcome measure
- 181
- Name it in a primary outcome, 34%
- 61 of 181
Tests named in the same studies
- 1
Trail Making Test104 studies, 35 as a primary outcome
- 2
Verbal Learning79 studies, 34 as a primary outcome
- 3
Verbal Fluency76 studies, 24 as a primary outcome
- 4
Category Fluency65 studies, 19 as a primary outcome
- 5
Picture Naming Test44 studies, 14 as a primary outcome
- 6
Stroop Color-Word Test39 studies, 17 as a primary outcome
- 7
Short Story Recall37 studies, 16 as a primary outcome
- 8
Symbol Coding36 studies, 16 as a primary outcome
- 9
Complex Figure Copy and Recall27 studies, 12 as a primary outcome
- 10
Clock Drawing Task20 studies, 8 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 4 | 2 |
| 2009 | 3 | 1 |
| 2010 | 8 | 3 |
| 2011 | 4 | 3 |
| 2012 | 5 | 2 |
| 2013 | 4 | 1 |
| 2014 | 5 | 3 |
| 2015 | 10 | 3 |
| 2016 | 5 | 1 |
| 2017 | 10 | 2 |
| 2018 | 8 | 1 |
| 2019 | 16 | 5 |
| 2020 | 7 | 2 |
| 2021 | 14 | 6 |
| 2022 | 12 | 4 |
| 2023 | 18 | 5 |
| 2024 | 16 | 8 |
| 2025 | 17 | 3 |
| 2026 | 10 | 4 |
Phases and study sizes
By phase
- Early phase 11 studies, 0 as a primary outcome
- Phase 13 studies, 0 as a primary outcome
- Phase 1/27 studies, 1 as a primary outcome
- Phase 223 studies, 7 as a primary outcome
- Phase 2/34 studies, 0 as a primary outcome
- Phase 38 studies, 3 as a primary outcome
- Phase 44 studies, 0 as a primary outcome
- Not applicable106 studies, 36 as a primary outcome
- Observational25 studies, 14 as a primary outcome
Participants per study
- Phase 257 median, 33 to 172
- Not applicable60 median, 40 to 137
- Observational165 median, 79 to 884
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 22 | 57 | 33 to 172 |
| Not applicable | 106 | 60 | 40 to 137 |
| Observational | 24 | 165 | 79 to 884 |
When dementia and Alzheimer's trials measure it
Latest time point of each outcome
- Within a day10 outcomes, 6 as a primary outcome
- Up to 4 weeks16 outcomes, 5 as a primary outcome
- 1 to 3 months34 outcomes, 10 as a primary outcome
- 3 to 6 months36 outcomes, 11 as a primary outcome
- 6 to 12 months35 outcomes, 6 as a primary outcome
- 1 to 2 years24 outcomes, 6 as a primary outcome
- Over 2 years18 outcomes, 11 as a primary outcome
- No duration given8 outcomes, 6 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
173 of the 181 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting30 studies, 12 as a primary outcome
- Not yet recruiting12 studies, 4 as a primary outcome
- Active, not recruiting9 studies, 4 as a primary outcome
- Completed87 studies, 30 as a primary outcome
- Stopped early16 studies, 5 as a primary outcome
- Status unknown27 studies, 6 as a primary outcome
What they test
- Behavioral51 studies, 22 as a primary outcome
- Drug35 studies, 7 as a primary outcome
- Device41 studies, 11 as a primary outcome
- Dietary supplement7 studies, 0 as a primary outcome
- Procedure7 studies, 3 as a primary outcome
- Diagnostic test5 studies, 0 as a primary outcome
- Biological7 studies, 1 as a primary outcome
- Radiation1 studies, 1 as a primary outcome
- Combination product1 studies, 1 as a primary outcome
- Genetic1 studies, 1 as a primary outcome
- Other40 studies, 15 as a primary outcome
- None given12 studies, 9 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States56 studies, 17 as a primary outcome
- Canada19 studies, 4 as a primary outcome
- China17 studies, 4 as a primary outcome
- Italy17 studies, 6 as a primary outcome
- United Kingdom17 studies, 8 as a primary outcome
- Australia15 studies, 3 as a primary outcome
- Spain14 studies, 3 as a primary outcome
- Sweden11 studies, 3 as a primary outcome
- France10 studies, 4 as a primary outcome
- Germany10 studies, 2 as a primary outcome
- Netherlands9 studies, 1 as a primary outcome
- Singapore7 studies, 4 as a primary outcome
54 countries in all. A study with sites in several counts in each; 15 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed dementia and Alzheimer's disease studies that name the Digit Span Test: 52 of 87, 60%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed dementia and Alzheimer's disease studies that name the Digit Span Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 15, 17% | 776, 10% |
| Results on ClinicalTrials.gov only | 9, 10% | 1,139, 14% |
| A results paper only | 28, 32% | 1,711, 22% |
| Neither | 35, 40% | 4,327, 54% |
The 181 studies
181 studies match. 61 name the Digit Span Test in a primary outcome. Median size 70 participants. Median time to the primary outcome: 6 months.
Loading 181 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 1 that started before 2000 and 1 planned to start after 2026.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 4 | 2 |
| 2009 | 3 | 1 |
| 2010 | 8 | 3 |
| 2011 | 4 | 3 |
| 2012 | 5 | 2 |
| 2013 | 4 | 1 |
| 2014 | 5 | 3 |
| 2015 | 10 | 3 |
| 2016 | 5 | 1 |
| 2017 | 10 | 2 |
| 2018 | 8 | 1 |
| 2019 | 16 | 5 |
| 2020 | 7 | 2 |
| 2021 | 14 | 6 |
| 2022 | 12 | 4 |
| 2023 | 18 | 5 |
| 2024 | 16 | 8 |
| 2025 | 17 | 3 |
| 2026 | 10 | 4 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 30, other 151. Interventional 156, observational 25.
As a primary outcomeSecondary or other outcomeThe Digit Span Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07883148 | Start2024 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants52 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07882251 | Start2021 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants80 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07779863 | Start2027 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants188 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07766993 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants100 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07731334 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants384 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07722169 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants48 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07673770 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07672977 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants30 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07667478 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07629349 | Start2020 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants600 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07618481 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants90 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07543094 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07505784 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07399418 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07392723 | Start2025 | PhasePhase 2 | ConditionsDementia and Alzheimer's, Aging, frailty and exercise | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07385937 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants150 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07376135 | Start2026 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants300 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07375771 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07241598 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants70 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07230158 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants160 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07210528 | Start2025 | PhasePhase 1 | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants48 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07109999 | Start2019 | PhaseObservational | ConditionsDementia and Alzheimer's | Participants2,835 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07089303 | Start2025 | PhaseObservational | ConditionsDementia and Alzheimer's, Mild cognitive impairment | Participants750 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07087951 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's | Participants70 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07064382 | Start2025 | PhaseNot applicable | ConditionsDementia and Alzheimer's, Sleep and sleep disorders | Participants60 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
Questions, answered from the data
How many dementia and Alzheimer's trials use the Digit Span Test?
181 registered dementia and Alzheimer's disease studies on ClinicalTrials.gov name it in an outcome measure, 61 of them in a primary outcome: 11% of the condition's 1,673 studies with a cognitive outcome, against 10% of all of them. It is the 4th most named test in dementia and Alzheimer's trials.
Which tests do dementia and Alzheimer's trials use with the Digit Span Test?
The Trail Making Test (104 studies), Verbal Learning (79 studies) and Verbal Fluency (76 studies).
How many participants do phase 2 dementia and Alzheimer's trials that use the Digit Span Test enroll?
Half of the phase 2 studies that name it enroll 57 participants or fewer, and the middle half enroll 33 to 172. 22 of them give a size.
When do dementia and Alzheimer's trials measure the Digit Span Test?
Half of the primary outcomes that name the Digit Span Test are measured within 6 months of the start, and the middle half from 9 weeks to 2 years. 55 primary outcomes give a duration.
How many completed dementia and Alzheimer's trials that use the Digit Span Test have reported results?
52 of the 87 completed studies that name it, 60%, have reported results: 24 posted them on ClinicalTrials.gov, 43 have a results paper linked to the registry record, and 15 did both. The other 35 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run the Digit Span Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.